Early Increase in Ammonia Is A Feature of Non-Alcoholic Fatty Liver Disease and the Ammonia Lowering Drug, Ornithine Phenylacetate (OCR002) Prevents Progression of Fibrosis in A Rodent Model.

Subjects

Subjects :

*AMMONIA in the body
*FATTY liver
*THERAPEUTICS
*PHENYLACETATES
*FIBROSIS
*DISEASE progression
*PREVENTION

Details

Language :

English

ISSN :

09736883

Volume :

7

Database :

Academic Search Index

Journal :

Journal of Clinical & Experimental Hepatology

Publication Type :

Academic Journal

Accession number :

121358316

Full Text :

https://doi.org/10.1016/j.jceh.2017.01.099